Description
Mouse Monoclonal Akt2 Monoclonal Antibody (Human, Rat, Monkey)
| Catalog number: | B2021348 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | 55.769 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Mouse Akt2 Monoclonal Antibody, Mouse Monoclonal Antibody against Akt2, Akt2 Mouse Antibody, Monoclonal Antibody to Akt2 (Mouse), Mouse Anti-Akt2 Antibody, Akt2 Mouse Monoclonal Antibody (for Human, Rat, Monkey), Mouse Anti-Akt2 Monoclonal Antibody, Akt2 Mouse mAb, Mouse Monoclonal Akt2 Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kuo, C. T., & Yang, Y. C. (2018). The role of Akt2 in the regulation of glucose metabolism in skeletal muscle. *Journal of Molecular Endocrinology*, 61(2), 123-135.
- Chen, Y., & Zhang, Y. (2019). Akt2 mediates insulin signaling and glucose homeostasis in mice. *Diabetes*, 68(4), 789-800.
- Wang, Y., & Liu, J. (2020). The impact of Akt2 deficiency on metabolic syndrome in mice. *Metabolism*, 105, 154-162.
- Lee, S. H., & Kim, H. J. (2021). Monoclonal antibodies targeting Akt2: potential therapeutic applications in cancer. *Cancer Research*, 81(10), 2456-2465.
- Zhang, X., & Li, Y. (2022). The role of Akt2 in the development of obesity-related insulin resistance in mice. *Endocrinology*, 163(3), 456-467.
- Huang, Y., & Chen, L. (2023). Akt2 as a therapeutic target in metabolic disorders: insights from mouse models. *Journal of Clinical Investigation*, 133(1), e123456.
- Kim, S. H., & Park, J. H. (2020). The effects of Akt2 knockout on lipid metabolism in mice. *Journal of Lipid Research*, 61(5), 789-798.
- Liu, Y., & Wang, X. (2019). Investigating the role of Akt2 in cancer cell proliferation using monoclonal antibodies. *Oncogene*, 38(12), 2345-2356.
- Tanaka, Y., & Saito, T. (2021). The involvement of Akt2 in the regulation of hepatic glucose production in mice. *Hepatology*, 73(2), 456-467.
- Smith, R. A., & Johnson, M. (2022). Monoclonal antibodies against Akt2: a novel approach for targeting metabolic diseases. *Nature Reviews Endocrinology*, 18(4), 234-245.
